Is JACC a Good Journal?

JACC's 22.3 impact factor places it among the top cardiology journals globally. But impact factor alone doesn't capture JACC's editorial selectivity.

The acceptance rate tells a more complete story. For context, JACC is more selective than most specialty journals. But unlike Nature, which desk-rejects based on novelty and broad significance, JACC desk-rejects based on clinical relevance and immediate applicability.

JACC's review timeline:

• Initial editorial decision: 14-21 days
• Peer review (if accepted for review): 6-8 weeks
• Revision cycle: 4-6 weeks
• Final decision: typically within 4 months of submission

The fast initial decision reflects editorial efficiency, not superficial review. JACC editors can quickly identify whether a study meets their clinical relevance threshold. Papers that don't get triaged out immediately, but fit doesn't guarantee acceptance.

About 85% of submissions get desk-rejected without peer review. Of the remaining 15% that go to external reviewers, roughly one-third eventually get accepted. This means your odds improve dramatically if you make it past the initial editorial screen.

The journal's citation patterns reveal its clinical focus. JACC papers get cited heavily in practice guidelines, systematic reviews, and clinical decision tools. The average JACC paper receives 40-60 citations within three years, with the highest-cited papers reaching into the hundreds.

JACC publishes research from major academic medical centers, but institutional prestige alone doesn't guarantee acceptance. The journal's published authors share certain characteristics that reflect editorial preferences rather than academic politics.

Successful JACC authors typically have:

• Access to large patient populations or multicenter networks
• Established track records in clinical research methodology
• Collaborative relationships with multiple institutions
• Funding that supports adequately powered studies
• Experience writing for clinical audiences

Interventional cardiology and heart failure studies dominate JACC's pages, reflecting both the subspecialty's research output and its immediate clinical relevance. Preventive cardiology, cardiac imaging, and electrophysiology also publish regularly, but usually with larger sample sizes and clearer practice implications than they'd need for subspecialty journals.

The most successful JACC papers often emerge from established research networks: multicenter consortiums, device registries, or long-running clinical trials. Single-center studies can succeed, but they typically need exceptional sample sizes or address questions that multicenter studies can't tackle effectively.

Common author profiles:

• Principal investigators of major cardiovascular trials
• Leaders of national or international registries
• Interventional cardiologists with access to large case volumes
• Health services researchers focusing on cardiovascular outcomes
• Meta-analysis experts with systematic review experience

Geographic diversity matters less than research quality, but North American and European authors publish more frequently than researchers from other regions. This likely reflects funding availability, institutional research infrastructure, and familiarity with JACC's editorial expectations rather than editorial bias.

The three top-tier cardiology journals serve slightly different niches despite overlapping prestige.

JACC: Clinical practice focus, fastest editorial decisions, strongest interventional cardiology presence

Circulation: Broader scope including basic science, longer review process, emphasis on pathophysiology

European Heart Journal: International perspective, prevention focus, growing influence in global cardiology

Choose JACC when your research will immediately change clinical practice. Choose Circulation when you're bridging basic science and clinical application. Choose European Heart Journal when your work addresses global cardiovascular health or prevention strategies.

JACC works best for specific types of cardiovascular research. Your paper fits if you can answer "yes" to most of these criteria:

Your research characteristics:

• Sample size exceeds 500 patients (or exceptional circumstances justify smaller numbers)
• Results will influence clinical practice within 1-2 years
• Methods are rigorous enough to support definitive conclusions
• Findings address questions that practicing cardiologists actually face
• Data comes from multiple centers or represents broad populations

Your study design:

• Randomized controlled trial with adequate power
• Large registry analysis with clinical endpoints
• Meta-analysis that resolves clinical uncertainty
• Comparative effectiveness research with clear winners
• Clinical prediction rule ready for implementation

Your target audience:

• Practicing cardiologists making treatment decisions
• Guideline committees developing recommendations
• Healthcare systems implementing new protocols
• Regulatory agencies evaluating new interventions

How to Choose the Right Journal for Your Paper (A Practical Guide) can help you evaluate whether JACC aligns with your research goals and target audience.

The strongest JACC submissions address clinical questions that don't have satisfactory answers yet. If your research settles a clinical debate or provides definitive evidence for practice change, JACC editors pay attention regardless of your institutional affiliation or previous publication record.